ERIKA CONCEPCION: Open Payments
NPI 1477844660 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,031 in 222 payments from 13 companies in 2025. Trend: 2023 $72,959 · 2024 $51,320 · 2025 $107,031
Speaker / faculty: $66,120Consulting: $15,560Honoraria: $14,300Travel & lodging: $5,850Food & beverage: $5,201
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 30 | $22,921 |
| Neurocrine BioSciences, Inc. | 30 | $19,075 |
| Alkermes, Inc. | 26 | $17,568 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $16,112 |
| Axsome Therapeutics, Inc. | 21 | $15,970 |
| E.R. Squibb & Sons, L.L.C. | 26 | $10,078 |
| ABBVIE INC. | 44 | $4,975 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Braeburn Inc. | 4 | $63 |
| Lundbeck LLC | 4 | $59 |
Products named: AUSTEDO XR, INGREZZA, CAPLYTA, Auvelity, LYBALVI, COBENFY, ARISTADA, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
